Figure 2
Figure 2. Transcriptomic profile of EVI1-r AMLs. (A) Comparative analysis of expressed genes in EVI-r AMLs compared with AMLs without EVI1 rearrangements. Among expressed genes (ie, those with an average log10 expression ≥3, corresponding approximately to a reads per kilobase of transcript per million reads mapped [RPKM] of 0.1), the 20 most differentially expressed in EVI1-r AMLs are highlighted (solid rhombuses, also detailed in supplemental Table 7A). Color of dots shows the false discovery rate q-values. (B) Comparative analysis of MECOM, PREX2, MYCT1, VIP, and PAWR expression between EVI1-r AML, AML without EVI1 rearrangements, and normal CD34+ cord blood-derived cells. *P < .05, **P < .005, and ***P < .0005.

Transcriptomic profile of EVI1-r AMLs. (A) Comparative analysis of expressed genes in EVI-r AMLs compared with AMLs without EVI1 rearrangements. Among expressed genes (ie, those with an average log10 expression ≥3, corresponding approximately to a reads per kilobase of transcript per million reads mapped [RPKM] of 0.1), the 20 most differentially expressed in EVI1-r AMLs are highlighted (solid rhombuses, also detailed in supplemental Table 7A). Color of dots shows the false discovery rate q-values. (B) Comparative analysis of MECOM, PREX2, MYCT1, VIP, and PAWR expression between EVI1-r AML, AML without EVI1 rearrangements, and normal CD34+ cord blood-derived cells. *P < .05, **P < .005, and ***P < .0005.

Close Modal

or Create an Account

Close Modal
Close Modal